Neuphoria Therapeutics (NEUP): Lynx1 Master Fund Slams Board Over Dilution, Governance Failures, and Launches Bid to Elect Independent Directors
December 2, 2025
Dear Fellow Neuphoria Shareholders,
Lynx1 Master Fund LP (together with its affiliates, “Lynx1” or “we”) is currently
Galloway Capital Pressures Noodles & Company (NDLS) to Sell Stores and Cut Debt in Activist Value Push
December 1, 2025
Joe Christina
President and Chief Executive Officer
Noodles & Company
520 Zang Street, Suite D
Broomfield, CO
Engine Capital Pressures UniFirst (UNF) on Governance Failures and Demands Strategic Review After Rejected Takeover Offers
Company Name: UniFirst Corporation
Symbol: UNF
Filing Date: Dec-01-2025
Filer Name: Engine Capital LP
Download PresentationEngine Capital-Dec-01-2025.pdf3 MBdownload-circle
Source:
UniFirst Corporation (UNF): Engine Capital Slams Governance Failures and Urges Immediate Strategic Review, Including a Potential Sale
UniFirst Corporation
68 Jonspin Road
Wilmington, Massachusetts 01887
Attention: Joseph M. Nowicki, Sergio A. Pupkin, Raymond C. Zemlin, Cecilia McKenney,
Neuphoria Therapeutics (NEUP): Lynx1 Capital Pushes Board Shake-Up After Dilution, Missteps, and Failed Phase 3 Trial
Company Name: Neuphoria Therapeutics Inc.
Symbol: NEUP
Filing Date: Nov-26-2025
Filer Name: Lynx1 Capital Management LP
Download PresentationLynx1-11-26-2025.pdf7 MBdownload-circle
Cannae Holdings (CNNE): Carronade Capital Demands Board Overhaul Amid Value Destruction and Conflicted Governance
Company Name: Cannae Holdings, Inc.
Symbol: CNNE
Filing Date: Nov-24-2025
Filer Name: Carronade Capital Management LP.
Download PresentationCarronade-Nov-24-2025.pdf2 MBdownload-circle
Member discussion